Johnson & Johnson (JNJ) Tops Q3 EPS by 4c; Boosts FY12 EPS Outlook
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $1.25, $0.04 better than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
